How to Source Tizanidine tablets/capsules for Pharmaceutical Formulation
Tizanidine tablets/capsules (Oral Capsules/Tablets, 2 mg and 4 mg) is classified under Multiple sclerosis. It is therapeutically aligned with reference brands such as Zanaflex (US). This guide highlights key sourcing factors buyers should consider when procuring high-quality Tizanidine tablets/capsules for formulation, R&D, or bulk manufacturing.
Product Overview:
Tizanidine is a muscle relaxant that acts on alpha-2 adrenergic receptors, reducing nerve signaling and muscle spasm activity. It effectively relieves spasticity, decreases muscle stiffness, and improves movement. Benefits include quick symptom relief, muscle relaxation, and enhanced mobility, supporting better quality of life for patients with neurological conditions.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Tizanidine tablets/capsules must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Tizanidine tablets/capsules is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Tizanidine tablets/capsules is more than procurement—it’s a strategic partnership. With its oral capsules/tablets form and 2 mg and 4 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Tizanidine tablets/capsules.
Frequently Asked Questions For Sourcing of Tizanidine tablets/capsules
What is the typical lead time for Tizanidine tablets/capsules?
Lead times range from 4–6 weeks depending on supplier and region.
Is Tizanidine tablets/capsules available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Tizanidine tablets/capsules require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Tizanidine tablets/capsules?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Tizanidine tablets/capsules?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Tizanidine tablets/capsules?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Tizanidine tablets/capsules suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Tizanidine tablets/capsules be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Advertise on PharmaTradZ
Reach verified pharma buyers, suppliers & decision makers worldwide.
Explore Pharma Investment Opportunities
Connect with partners, startups & ventures driving the future of pharma.